Free Trial
NASDAQ:WORX

SCWorx Q4 2024 Earnings Results & Report

SCWorx logo
$1.94 -0.20 (-9.11%)
As of 01:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.

SCWorx reported Q4 2024 earnings on March 31, 2025. The company reported EPS of -$16.20, while revenue was $0.68 million.

Earnings Announcement Details

Quarter
Q4 2024
Report Date
Time
After Market Closes

SCWorx EPS Results

Actual EPS
-$16.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

SCWorx Revenue Results

Actual Revenue
$0.68 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

SCWorx Q4 2024 Earnings FAQ

SCWorx (NASDAQ:WORX) reported earnings of -$16.20 per share for Q4 2024. The report was announced on Monday, March 31, 2025.

SCWorx reported revenue of $0.68 million for Q4 2024.

SCWorx Earnings Headlines

My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel
SCWorx Announces Nasdaq Trading to Resume October 7, 2026
See More SCWorx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SCWorx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SCWorx and other key companies, straight to your email.

About SCWorx

SCWorx (NASDAQ:WORX) is a healthcare technology company that provides software and services designed to help healthcare organizations manage supply chains and related operational data. Its platform is intended to support the organization of medical product information, supplier relationships, purchasing processes and inventory management.

The company’s solutions have been marketed to hospitals, healthcare systems and other healthcare providers seeking greater visibility into medical supplies and procurement activities. SCWorx has also provided data-management and analytics capabilities intended to help customers improve product catalog accuracy, identify sourcing opportunities and coordinate supply-chain operations.

SCWorx was founded in 2012 and is headquartered in New York. The company has been led by Marc Schessel, who has served as its chief executive officer and chairman. Publicly available information about its current operations and geographic reach is limited, so the company’s activities and leadership may change over time.

View SCWorx Profile